APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oxcarbazepine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oxcarbazepine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026194 pages

Choose your research edition.

Industry ResearchOxcarbazepine Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxcarbazepine Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Oxcarbazepine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxcarbazepine Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxcarbazepine Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Oxcarbazepine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oxcarbazepine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oxcarbazepine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oxcarbazepine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oxcarbazepine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oxcarbazepine include Sihuan Pharm, Humanwell Healthcare, Novartis (Trileptal), Mylan, Huikang Pharmaceutical, Teva Pharmaceutical, Taro Pharmaceuticals, Supernus Pharmaceuticals (Oxtellar XR) and Sun Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oxcarbazepine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oxcarbazepine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oxcarbazepine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oxcarbazepine market size, projected growth trends, production technologies, key applications, and end-use industries.

Oxcarbazepine Segment by Company

Sihuan Pharm

Humanwell Healthcare

Novartis (Trileptal)

Mylan

Huikang Pharmaceutical

Teva Pharmaceutical

Taro Pharmaceuticals

Supernus Pharmaceuticals (Oxtellar XR)

Sun Pharm

Stada Group

Roxane Laboratories

Ranbaxy Pharmaceuticals

Orion Corporation

Nobelpharma

Nexgen pharma

Neuraxpharm

Jubilant Generics

Jamp Pharma

Hikma Pharmaceuticals

Glenmark Pharmaceuticals

Apotex

ANI Pharmaceuticals

Amneal Pharmaceuticals

Oxcarbazepine Segment by Type

Tablets (150mg, 300mg, 600mg)

Oral Suspension

Oxcarbazepine Segment by Application

Pediatric Use (Aged 2-4 years, 4-16 years)

Adult Use

Oxcarbazepine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxcarbazepine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxcarbazepine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxcarbazepine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oxcarbazepine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oxcarbazepine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oxcarbazepine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oxcarbazepine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oxcarbazepine Industry Trends Table 2. Oxcarbazepine Industry Drivers Table 3. Oxcarbazepine Industry Opportunities and Challenges Table 4. Oxcarbazepine Industry Restraints Table 5. Global Oxcarbazepine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oxcarbazepine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oxcarbazepine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Oxcarbazepine Sales Market Share by Manufacturers Table 9. Global Oxcarbazepine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Oxcarbazepine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oxcarbazepine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oxcarbazepine Manufacturers, Product Type & Application Table 13. Global Oxcarbazepine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oxcarbazepine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets (150mg, 300mg, 600mg) Table 17. Major Manufacturers of Oral Suspension Table 18. Global Oxcarbazepine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Oxcarbazepine Sales by Type (2021-2026) & (K Units) Table 20. Global Oxcarbazepine Sales by Type (2027-2032) & (K Units) Table 21. Global Oxcarbazepine Sales Market Share by Type (2021-2026) Table 22. Global Oxcarbazepine Sales Market Share by Type (2027-2032) Table 23. Global Oxcarbazepine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Oxcarbazepine Revenue by Type (2021-2026) & (K Units) Table 25. Global Oxcarbazepine Revenue by Type (2027-2032) & (K Units) Table 26. Global Oxcarbazepine Revenue Market Share by Type (2021-2026) Table 27. Global Oxcarbazepine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pediatric Use (Aged 2-4 years, 4-16 years) Table 29. Major Manufacturers of Adult Use Table 30. Global Oxcarbazepine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Oxcarbazepine Sales by Application (2021-2026) & (K Units) Table 32. Global Oxcarbazepine Sales by Application (2027-2032) & (K Units) Table 33. Global Oxcarbazepine Sales Market Share by Application (2021-2026) Table 34. Global Oxcarbazepine Sales Market Share by Application (2027-2032) Table 35. Global Oxcarbazepine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Oxcarbazepine Revenue by Application (2021-2026) & (K Units) Table 37. Global Oxcarbazepine Revenue by Application (2027-2032) & (K Units) Table 38. Global Oxcarbazepine Revenue Market Share by Application (2021-2026) Table 39. Global Oxcarbazepine Revenue Market Share by Application (2027-2032) Table 40. Global Oxcarbazepine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Oxcarbazepine Sales by Region (2021-2026) & (K Units) Table 42. Global Oxcarbazepine Sales Market Share by Region (2021-2026) Table 43. Global Oxcarbazepine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Oxcarbazepine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Oxcarbazepine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Oxcarbazepine Sales by Country (2021-2026) & (K Units) Table 47. North America Oxcarbazepine Sales by Country (2027-2032) & (K Units) Table 48. Europe Oxcarbazepine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Oxcarbazepine Sales by Country (2021-2026) & (K Units) Table 50. Europe Oxcarbazepine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Oxcarbazepine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Oxcarbazepine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Oxcarbazepine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Oxcarbazepine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Oxcarbazepine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Oxcarbazepine Sales by Country (2027-2032) & (K Units) Table 57. Global Oxcarbazepine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Oxcarbazepine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Oxcarbazepine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Oxcarbazepine Revenue Market Share by Region (2021-2026) Table 61. Global Oxcarbazepine Revenue Market Share by Region (2027-2032) Table 62. Sihuan Pharm Company Information Table 63. Sihuan Pharm Business Overview Table 64. Sihuan Pharm Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Sihuan Pharm Oxcarbazepine Product Portfolio Table 66. Sihuan Pharm Recent Development Table 67. Humanwell Healthcare Company Information Table 68. Humanwell Healthcare Business Overview Table 69. Humanwell Healthcare Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Humanwell Healthcare Oxcarbazepine Product Portfolio Table 71. Humanwell Healthcare Recent Development Table 72. Novartis (Trileptal) Company Information Table 73. Novartis (Trileptal) Business Overview Table 74. Novartis (Trileptal) Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Novartis (Trileptal) Oxcarbazepine Product Portfolio Table 76. Novartis (Trileptal) Recent Development Table 77. Mylan Company Information Table 78. Mylan Business Overview Table 79. Mylan Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Mylan Oxcarbazepine Product Portfolio Table 81. Mylan Recent Development Table 82. Huikang Pharmaceutical Company Information Table 83. Huikang Pharmaceutical Business Overview Table 84. Huikang Pharmaceutical Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Huikang Pharmaceutical Oxcarbazepine Product Portfolio Table 86. Huikang Pharmaceutical Recent Development Table 87. Teva Pharmaceutical Company Information Table 88. Teva Pharmaceutical Business Overview Table 89. Teva Pharmaceutical Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Teva Pharmaceutical Oxcarbazepine Product Portfolio Table 91. Teva Pharmaceutical Recent Development Table 92. Taro Pharmaceuticals Company Information Table 93. Taro Pharmaceuticals Business Overview Table 94. Taro Pharmaceuticals Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Taro Pharmaceuticals Oxcarbazepine Product Portfolio Table 96. Taro Pharmaceuticals Recent Development Table 97. Supernus Pharmaceuticals (Oxtellar XR) Company Information Table 98. Supernus Pharmaceuticals (Oxtellar XR) Business Overview Table 99. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product Portfolio Table 101. Supernus Pharmaceuticals (Oxtellar XR) Recent Development Table 102. Sun Pharm Company Information Table 103. Sun Pharm Business Overview Table 104. Sun Pharm Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Sun Pharm Oxcarbazepine Product Portfolio Table 106. Sun Pharm Recent Development Table 107. Stada Group Company Information Table 108. Stada Group Business Overview Table 109. Stada Group Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Stada Group Oxcarbazepine Product Portfolio Table 111. Stada Group Recent Development Table 112. Roxane Laboratories Company Information Table 113. Roxane Laboratories Business Overview Table 114. Roxane Laboratories Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Roxane Laboratories Oxcarbazepine Product Portfolio Table 116. Roxane Laboratories Recent Development Table 117. Ranbaxy Pharmaceuticals Company Information Table 118. Ranbaxy Pharmaceuticals Business Overview Table 119. Ranbaxy Pharmaceuticals Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Ranbaxy Pharmaceuticals Oxcarbazepine Product Portfolio Table 121. Ranbaxy Pharmaceuticals Recent Development Table 122. Orion Corporation Company Information Table 123. Orion Corporation Business Overview Table 124. Orion Corporation Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Orion Corporation Oxcarbazepine Product Portfolio Table 126. Orion Corporation Recent Development Table 127. Nobelpharma Company Information Table 128. Nobelpharma Business Overview Table 129. Nobelpharma Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Nobelpharma Oxcarbazepine Product Portfolio Table 131. Nobelpharma Recent Development Table 132. Nexgen pharma Company Information Table 133. Nexgen pharma Business Overview Table 134. Nexgen pharma Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Nexgen pharma Oxcarbazepine Product Portfolio Table 136. Nexgen pharma Recent Development Table 137. Neuraxpharm Company Information Table 138. Neuraxpharm Business Overview Table 139. Neuraxpharm Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Neuraxpharm Oxcarbazepine Product Portfolio Table 141. Neuraxpharm Recent Development Table 142. Jubilant Generics Company Information Table 143. Jubilant Generics Business Overview Table 144. Jubilant Generics Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Jubilant Generics Oxcarbazepine Product Portfolio Table 146. Jubilant Generics Recent Development Table 147. Jamp Pharma Company Information Table 148. Jamp Pharma Business Overview Table 149. Jamp Pharma Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Jamp Pharma Oxcarbazepine Product Portfolio Table 151. Jamp Pharma Recent Development Table 152. Hikma Pharmaceuticals Company Information Table 153. Hikma Pharmaceuticals Business Overview Table 154. Hikma Pharmaceuticals Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Hikma Pharmaceuticals Oxcarbazepine Product Portfolio Table 156. Hikma Pharmaceuticals Recent Development Table 157. Glenmark Pharmaceuticals Company Information Table 158. Glenmark Pharmaceuticals Business Overview Table 159. Glenmark Pharmaceuticals Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Glenmark Pharmaceuticals Oxcarbazepine Product Portfolio Table 161. Glenmark Pharmaceuticals Recent Development Table 162. Apotex Company Information Table 163. Apotex Business Overview Table 164. Apotex Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. Apotex Oxcarbazepine Product Portfolio Table 166. Apotex Recent Development Table 167. ANI Pharmaceuticals Company Information Table 168. ANI Pharmaceuticals Business Overview Table 169. ANI Pharmaceuticals Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 170. ANI Pharmaceuticals Oxcarbazepine Product Portfolio Table 171. ANI Pharmaceuticals Recent Development Table 172. Amneal Pharmaceuticals Company Information Table 173. Amneal Pharmaceuticals Business Overview Table 174. Amneal Pharmaceuticals Oxcarbazepine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 175. Amneal Pharmaceuticals Oxcarbazepine Product Portfolio Table 176. Amneal Pharmaceuticals Recent Development Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Oxcarbazepine Distributors List Table 180. Oxcarbazepine Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Oxcarbazepine Product Image Figure 2. Global Oxcarbazepine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxcarbazepine Market Size (2021-2032) & (US$ Million) Figure 4. Global Oxcarbazepine Sales (2021-2032) & (K Units) Figure 5. Global Oxcarbazepine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oxcarbazepine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets (150mg, 300mg, 600mg) Image Figure 9. Oral Suspension Image Figure 10. Global Oxcarbazepine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Oxcarbazepine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Oxcarbazepine Sales Market Share by Type (2021-2032) Figure 13. Global Oxcarbazepine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Oxcarbazepine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Oxcarbazepine Revenue Market Share by Type (2021-2032) Figure 16. Pediatric Use (Aged 2-4 years, 4-16 years) Image Figure 17. Adult Use Image Figure 18. Global Oxcarbazepine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Oxcarbazepine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Oxcarbazepine Sales Market Share by Application (2021-2032) Figure 21. Global Oxcarbazepine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Oxcarbazepine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Oxcarbazepine Revenue Market Share by Application (2021-2032) Figure 24. North America Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Oxcarbazepine Sales Market Share by Country (2021-2032) Figure 26. U.S. Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Oxcarbazepine Sales Market Share by Country (2021-2032) Figure 31. Germany Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Oxcarbazepine Sales Market Share by Country (2021-2032) Figure 38. China Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Oxcarbazepine Sales Market Share by Country (2021-2032) Figure 46. Brazil Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Oxcarbazepine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Oxcarbazepine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Oxcarbazepine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Oxcarbazepine Revenue (2021-2032) & (US$ Million) Figure 57. North America Oxcarbazepine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Oxcarbazepine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Oxcarbazepine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Oxcarbazepine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Oxcarbazepine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Oxcarbazepine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Oxcarbazepine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Oxcarbazepine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Oxcarbazepine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets (150mg, 300mg, 600mg)
  • Oral Suspension
Applications
  • Pediatric Use (Aged 2-4 years, 4-16 years)
  • Adult Use
Companies covered
  • Sihuan Pharm
  • Humanwell Healthcare
  • Novartis (Trileptal)
  • Mylan
  • Huikang Pharmaceutical
  • Teva Pharmaceutical
  • Taro Pharmaceuticals
  • Supernus Pharmaceuticals (Oxtellar XR)
  • Sun Pharm
  • Stada Group
  • Roxane Laboratories
  • Ranbaxy Pharmaceuticals
  • Orion Corporation
  • Nobelpharma
  • Nexgen pharma
  • Neuraxpharm
  • Jubilant Generics
  • Jamp Pharma
  • Hikma Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Apotex
  • ANI Pharmaceuticals
  • Amneal Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oxcarbazepine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oxcarbazepine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oxcarbazepine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oxcarbazepine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oxcarbazepine Market Dynamics
  1. 2.1 Oxcarbazepine Industry Trends
  2. 2.2 Oxcarbazepine Industry Drivers
  3. 2.3 Oxcarbazepine Industry Opportunities and Challenges
  4. 2.4 Oxcarbazepine Industry Restraints
3 Oxcarbazepine Market by Manufacturers
  1. 3.1 Global Oxcarbazepine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oxcarbazepine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oxcarbazepine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oxcarbazepine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oxcarbazepine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oxcarbazepine Manufacturers, Product Type & Application
  7. 3.7 Global Oxcarbazepine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oxcarbazepine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oxcarbazepine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oxcarbazepine Tier 1, Tier 2, and Tier 3
4 Oxcarbazepine Market by Type
  1. 4.1 Oxcarbazepine Type Introduction
  2. 4.1.1 Tablets (150mg, 300mg, 600mg)
  3. 4.1.2 Oral Suspension
  4. 4.2 Global Oxcarbazepine Sales by Type
  5. 4.2.1 Global Oxcarbazepine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oxcarbazepine Sales by Type (2021-2032)
  7. 4.2.3 Global Oxcarbazepine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Oxcarbazepine Revenue by Type
  9. 4.3.1 Global Oxcarbazepine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oxcarbazepine Revenue by Type (2021-2032)
  11. 4.3.3 Global Oxcarbazepine Revenue Market Share by Type (2021-2032)
5 Oxcarbazepine Market by Application
  1. 5.1 Oxcarbazepine Application Introduction
  2. 5.1.1 Pediatric Use (Aged 2-4 years, 4-16 years)
  3. 5.1.2 Adult Use
  4. 5.2 Global Oxcarbazepine Sales by Application
  5. 5.2.1 Global Oxcarbazepine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oxcarbazepine Sales by Application (2021-2032)
  7. 5.2.3 Global Oxcarbazepine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Oxcarbazepine Revenue by Application
  9. 5.3.1 Global Oxcarbazepine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oxcarbazepine Revenue by Application (2021-2032)
  11. 5.3.3 Global Oxcarbazepine Revenue Market Share by Application (2021-2032)
6 Global Oxcarbazepine Sales by Region
  1. 6.1 Global Oxcarbazepine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oxcarbazepine Sales by Region (2021-2032)
  3. 6.2.1 Global Oxcarbazepine Sales by Region (2021-2026)
  4. 6.2.2 Global Oxcarbazepine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oxcarbazepine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oxcarbazepine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oxcarbazepine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oxcarbazepine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oxcarbazepine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oxcarbazepine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oxcarbazepine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oxcarbazepine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oxcarbazepine Revenue by Region
  1. 7.1 Global Oxcarbazepine Revenue by Region
  2. 7.1.1 Global Oxcarbazepine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oxcarbazepine Revenue by Region (2021-2026)
  4. 7.1.3 Global Oxcarbazepine Revenue by Region (2027-2032)
  5. 7.1.4 Global Oxcarbazepine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oxcarbazepine Revenue (2021-2032)
  8. 7.2.2 North America Oxcarbazepine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oxcarbazepine Revenue (2021-2032)
  11. 7.3.2 Europe Oxcarbazepine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oxcarbazepine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oxcarbazepine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oxcarbazepine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oxcarbazepine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sihuan Pharm
  2. 8.1.1 Sihuan Pharm Company Information
  3. 8.1.2 Sihuan Pharm Business Overview
  4. 8.1.3 Sihuan Pharm Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sihuan Pharm Oxcarbazepine Product Portfolio
  6. 8.1.5 Sihuan Pharm Recent Developments
  7. 8.2 Humanwell Healthcare
  8. 8.2.1 Humanwell Healthcare Company Information
  9. 8.2.2 Humanwell Healthcare Business Overview
  10. 8.2.3 Humanwell Healthcare Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Humanwell Healthcare Oxcarbazepine Product Portfolio
  12. 8.2.5 Humanwell Healthcare Recent Developments
  13. 8.3 Novartis (Trileptal)
  14. 8.3.1 Novartis (Trileptal) Company Information
  15. 8.3.2 Novartis (Trileptal) Business Overview
  16. 8.3.3 Novartis (Trileptal) Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis (Trileptal) Oxcarbazepine Product Portfolio
  18. 8.3.5 Novartis (Trileptal) Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Oxcarbazepine Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Huikang Pharmaceutical
  26. 8.5.1 Huikang Pharmaceutical Company Information
  27. 8.5.2 Huikang Pharmaceutical Business Overview
  28. 8.5.3 Huikang Pharmaceutical Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Huikang Pharmaceutical Oxcarbazepine Product Portfolio
  30. 8.5.5 Huikang Pharmaceutical Recent Developments
  31. 8.6 Teva Pharmaceutical
  32. 8.6.1 Teva Pharmaceutical Company Information
  33. 8.6.2 Teva Pharmaceutical Business Overview
  34. 8.6.3 Teva Pharmaceutical Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Teva Pharmaceutical Oxcarbazepine Product Portfolio
  36. 8.6.5 Teva Pharmaceutical Recent Developments
  37. 8.7 Taro Pharmaceuticals
  38. 8.7.1 Taro Pharmaceuticals Company Information
  39. 8.7.2 Taro Pharmaceuticals Business Overview
  40. 8.7.3 Taro Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Taro Pharmaceuticals Oxcarbazepine Product Portfolio
  42. 8.7.5 Taro Pharmaceuticals Recent Developments
  43. 8.8 Supernus Pharmaceuticals (Oxtellar XR)
  44. 8.8.1 Supernus Pharmaceuticals (Oxtellar XR) Company Information
  45. 8.8.2 Supernus Pharmaceuticals (Oxtellar XR) Business Overview
  46. 8.8.3 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Supernus Pharmaceuticals (Oxtellar XR) Oxcarbazepine Product Portfolio
  48. 8.8.5 Supernus Pharmaceuticals (Oxtellar XR) Recent Developments
  49. 8.9 Sun Pharm
  50. 8.9.1 Sun Pharm Company Information
  51. 8.9.2 Sun Pharm Business Overview
  52. 8.9.3 Sun Pharm Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sun Pharm Oxcarbazepine Product Portfolio
  54. 8.9.5 Sun Pharm Recent Developments
  55. 8.10 Stada Group
  56. 8.10.1 Stada Group Company Information
  57. 8.10.2 Stada Group Business Overview
  58. 8.10.3 Stada Group Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Stada Group Oxcarbazepine Product Portfolio
  60. 8.10.5 Stada Group Recent Developments
  61. 8.11 Roxane Laboratories
  62. 8.11.1 Roxane Laboratories Company Information
  63. 8.11.2 Roxane Laboratories Business Overview
  64. 8.11.3 Roxane Laboratories Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Roxane Laboratories Oxcarbazepine Product Portfolio
  66. 8.11.5 Roxane Laboratories Recent Developments
  67. 8.12 Ranbaxy Pharmaceuticals
  68. 8.12.1 Ranbaxy Pharmaceuticals Company Information
  69. 8.12.2 Ranbaxy Pharmaceuticals Business Overview
  70. 8.12.3 Ranbaxy Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ranbaxy Pharmaceuticals Oxcarbazepine Product Portfolio
  72. 8.12.5 Ranbaxy Pharmaceuticals Recent Developments
  73. 8.13 Orion Corporation
  74. 8.13.1 Orion Corporation Company Information
  75. 8.13.2 Orion Corporation Business Overview
  76. 8.13.3 Orion Corporation Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Orion Corporation Oxcarbazepine Product Portfolio
  78. 8.13.5 Orion Corporation Recent Developments
  79. 8.14 Nobelpharma
  80. 8.14.1 Nobelpharma Company Information
  81. 8.14.2 Nobelpharma Business Overview
  82. 8.14.3 Nobelpharma Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Nobelpharma Oxcarbazepine Product Portfolio
  84. 8.14.5 Nobelpharma Recent Developments
  85. 8.15 Nexgen pharma
  86. 8.15.1 Nexgen pharma Company Information
  87. 8.15.2 Nexgen pharma Business Overview
  88. 8.15.3 Nexgen pharma Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nexgen pharma Oxcarbazepine Product Portfolio
  90. 8.15.5 Nexgen pharma Recent Developments
  91. 8.16 Neuraxpharm
  92. 8.16.1 Neuraxpharm Company Information
  93. 8.16.2 Neuraxpharm Business Overview
  94. 8.16.3 Neuraxpharm Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Neuraxpharm Oxcarbazepine Product Portfolio
  96. 8.16.5 Neuraxpharm Recent Developments
  97. 8.17 Jubilant Generics
  98. 8.17.1 Jubilant Generics Company Information
  99. 8.17.2 Jubilant Generics Business Overview
  100. 8.17.3 Jubilant Generics Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Jubilant Generics Oxcarbazepine Product Portfolio
  102. 8.17.5 Jubilant Generics Recent Developments
  103. 8.18 Jamp Pharma
  104. 8.18.1 Jamp Pharma Company Information
  105. 8.18.2 Jamp Pharma Business Overview
  106. 8.18.3 Jamp Pharma Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Jamp Pharma Oxcarbazepine Product Portfolio
  108. 8.18.5 Jamp Pharma Recent Developments
  109. 8.19 Hikma Pharmaceuticals
  110. 8.19.1 Hikma Pharmaceuticals Company Information
  111. 8.19.2 Hikma Pharmaceuticals Business Overview
  112. 8.19.3 Hikma Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Hikma Pharmaceuticals Oxcarbazepine Product Portfolio
  114. 8.19.5 Hikma Pharmaceuticals Recent Developments
  115. 8.20 Glenmark Pharmaceuticals
  116. 8.20.1 Glenmark Pharmaceuticals Company Information
  117. 8.20.2 Glenmark Pharmaceuticals Business Overview
  118. 8.20.3 Glenmark Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Glenmark Pharmaceuticals Oxcarbazepine Product Portfolio
  120. 8.20.5 Glenmark Pharmaceuticals Recent Developments
  121. 8.21 Apotex
  122. 8.21.1 Apotex Company Information
  123. 8.21.2 Apotex Business Overview
  124. 8.21.3 Apotex Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Apotex Oxcarbazepine Product Portfolio
  126. 8.21.5 Apotex Recent Developments
  127. 8.22 ANI Pharmaceuticals
  128. 8.22.1 ANI Pharmaceuticals Company Information
  129. 8.22.2 ANI Pharmaceuticals Business Overview
  130. 8.22.3 ANI Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 ANI Pharmaceuticals Oxcarbazepine Product Portfolio
  132. 8.22.5 ANI Pharmaceuticals Recent Developments
  133. 8.23 Amneal Pharmaceuticals
  134. 8.23.1 Amneal Pharmaceuticals Company Information
  135. 8.23.2 Amneal Pharmaceuticals Business Overview
  136. 8.23.3 Amneal Pharmaceuticals Oxcarbazepine Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Amneal Pharmaceuticals Oxcarbazepine Product Portfolio
  138. 8.23.5 Amneal Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oxcarbazepine Value Chain Analysis
  2. 9.1.1 Oxcarbazepine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oxcarbazepine Production Mode & Process
  6. 9.2 Oxcarbazepine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oxcarbazepine Distributors
  9. 9.2.3 Oxcarbazepine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst